Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 40 of 250 for:    Venetoclax

Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AML

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03709758
Recruitment Status : Recruiting
First Posted : October 17, 2018
Last Update Posted : March 31, 2020
Sponsor:
Collaborators:
AbbVie
Genentech, Inc.
Information provided by (Responsible Party):
Richard Stone, MD, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 1, 2023
Estimated Study Completion Date : June 1, 2025